Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Brain Neoplasms × nabiximols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 3 Neoplasms 3 Marijuana Abuse 3 Recurrence 1 Parasomnias 1 Pancreatic Neoplasms 1 Nausea 1 Glioblastoma 1 Chronic Pain 1 Cachexia 1 Brain Neoplasms 1 Anxiety Disorders 1 Anorexia 1 Advanced Malignant Solid Tumor 1

Interventions

Temozolomide 63 Bevacizumab 52 Radiotherapy 35 Radiosurgery 26 Carboplatin 21 pembrolizumab 15 Etoposide 15 Nivolumab 14 Irinotecan 14 Cisplatin 13 Carmustine 13 Magnetic Resonance Spectroscopy 12 Ipilimumab 12 Erlotinib Hydrochloride 12 Cyclophosphamide 12 Pemetrexed 11 Surgical Procedures, Operative 10 Topotecan 9 Lapatinib 9 Capecitabine 9 Thalidomide 8 Aminolevulinic Acid 8 Lomustine 7 Imatinib Mesylate 7 Gefitinib 7 Filgrastim 7 trametinib 6 osimertinib 6 encorafenib 6 cabozantinib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05629702 2026-01-30

ARISTOCRAT

University of Birmingham

Phase 2 Recruiting

Brain Neoplasms, Marijuana Abuse, Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡